AI and Machine Learning Revolutionize Anti-Aging Drug Discovery.
TL;DR
Researchers have developed a deep neural network-based approach to identify small-molecule senolytics, drugs that selectively eliminate senescent cells, which contribute to aging and age-related diseases. The approach was able to identify several new senolytic compounds, which were validated in vitro and in vivo. The study demonstrates the potential of machine learning in drug discovery for aging and age-related diseases.
Topics:healthbiomedical-research#aging#biomedical-research#deep-neural-networks#drug-discovery#machine-learning#senolytics
- Discovering small-molecule senolytics with deep neural networks Nature.com
- Three Novel Anti-Aging Senolytics Discovered Using AI and Synbio Genetic Engineering & Biotechnology News
- Using Machine Learning to Find Senolytics Lifespan.io News
- California startup with MIT roots harnessing AI to target age-related diseases The Boston Globe
- These high school students are racing to find faster brain cancer treatments Fox News
- View Full Coverage on Google News
Want the full story? Read the original reporting
Read on Nature.com